A new trading day began on Monday, with Twist Bioscience Corp (NASDAQ: TWST) stock price up 12.31% from the previous day of trading, before settling in for the closing price of $36.89. TWST’s price has ranged from $18.80 to $60.90 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 55.03% over the past five years. Meanwhile, its annual earnings per share averaged 36.07%. With a float of $55.59 million, this company’s outstanding shares have now reached $57.56 million.
Let’s look at the performance matrix of the company that is accounted for 919 employees. In terms of profitability, gross margin is 42.61%, operating margin of -70.56%, and the pretax margin is -66.45%.
Twist Bioscience Corp (TWST) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Twist Bioscience Corp is 5.12%, while institutional ownership is 111.59%. The most recent insider transaction that took place on Nov 11 ’24, was worth 170,139. In this transaction Director of this company sold 3,600 shares at a rate of $47.26, taking the stock ownership to the 21,641 shares. Before that another transaction happened on Nov 11 ’24, when Company’s insider sold 1,507 for $48.00, making the entire transaction worth $72,333. This insider now owns 91,163 shares in total.
Twist Bioscience Corp (TWST) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 36.07% per share during the next fiscal year.
Twist Bioscience Corp (NASDAQ: TWST) Trading Performance Indicators
Here are Twist Bioscience Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.54. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.34.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.60, a number that is poised to hit -0.65 in the next quarter and is forecasted to reach -1.67 in one year’s time.
Technical Analysis of Twist Bioscience Corp (TWST)
Twist Bioscience Corp (NASDAQ: TWST) saw its 5-day average volume 1.49 million, a positive change from its year-to-date volume of 0.95 million. As of the previous 9 days, the stock’s Stochastic %D was 13.49%. Additionally, its Average True Range was 2.88.
During the past 100 days, Twist Bioscience Corp’s (TWST) raw stochastic average was set at 19.83%, which indicates a significant decrease from 38.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 85.36% in the past 14 days, which was higher than the 68.82% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $43.98, while its 200-day Moving Average is $42.69. Nevertheless, the first resistance level for the watch stands at $43.84 in the near term. At $46.25, the stock is likely to face the second major resistance level. The third major resistance level sits at $48.15. If the price goes on to break the first support level at $39.53, it is likely to go to the next support level at $37.63. The third support level lies at $35.22 if the price breaches the second support level.
Twist Bioscience Corp (NASDAQ: TWST) Key Stats
With a market capitalization of 2.30 billion, the company has a total of 58,586K Shares Outstanding. Currently, annual sales are 245,110 K while annual income is -204,620 K. The company’s previous quarter sales were 81,460 K while its latest quarter income was -85,570 K.
